Stay updated on Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Sign up to get notified when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.

Latest updates to the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.5.3 has been added to the record history. The previous revision v3.5.2 has been removed from the history, reflecting an update to the metadata of the study record.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision history shows an addition of v3.4.3 and a deletion of v3.4.2.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 was added to the page history. The prior Notice about government funding and the Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check95 days agoChange DetectedA new notice about government funding status and NIH Clinical Center operations appears on the page. The page now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.5%

Stay in the know with updates to Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andexanet Alfa in ICrH with Oral FXa Inhibitor: Clinical Trial page.